Merrimack Pharmaceuticals Inc MACK
Institutional shares held
349
0
calls
0
puts
Total value of holdings
$5K
$0
calls
$0
puts
Market Cap
$203M
13,410,200
Shares Out.
Institutional ownership
0.0%
# of Institutions
2
We take great care to ensure that the data presented and summarized in this overview for MERRIMACK PHARMACEUTICALS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in MACK
Top Purchases
Top Sells
About MACK
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
Insider Transactions at MACK
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 28
2023
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
857
+0.16%
|
$11,141
$13.35 P/Share
|
|
Dec 26
2023
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
48,693
+8.37%
|
$633,009
$13.15 P/Share
|
|
Dec 07
2023
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
101,050
+4.53%
|
$1,212,600
$12.85 P/Share
|
|
Nov 17
2023
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
300
+0.01%
|
$3,600
$12.5 P/Share
|
|
Nov 14
2023
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
50,170
+2.31%
|
$602,040
$12.5 P/Share
|
|
Nov 13
2023
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
15,570
+0.75%
|
$186,840
$12.39 P/Share
|
|
Nov 10
2023
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
38,062
+1.82%
|
$456,744
$12.32 P/Share
|
|
Nov 09
2023
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
9,975
+0.49%
|
$119,700
$12.19 P/Share
|
|
Nov 08
2023
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
13,823
+1.17%
|
$165,876
$12.13 P/Share
|
|
Aug 11
2023
|
Gary L Crocker |
BUY
Open market or private purchase
|
Indirect |
2,000
+1.48%
|
$24,000
$12.43 P/Share
|
|
Aug 10
2023
|
Gary L Crocker |
BUY
Open market or private purchase
|
Indirect |
2,000
+1.48%
|
$24,000
$12.52 P/Share
|
|
Aug 08
2023
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
87,057
+4.19%
|
$1,044,684
$12.0 P/Share
|
|
Aug 07
2023
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
134,493
+8.13%
|
$1,613,916
$12.0 P/Share
|
|
Mar 21
2023
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
160,590
+8.38%
|
$1,766,490
$11.52 P/Share
|
|
Jan 31
2023
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
2,232
+0.14%
|
$24,552
$11.4 P/Share
|
|
Jan 30
2023
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
24,708
+1.51%
|
$271,788
$11.36 P/Share
|
|
Jan 27
2023
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
21,875
+1.36%
|
$240,625
$11.4 P/Share
|
|
Jan 12
2023
|
Noah G. Levy Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+8.2%
|
$1,100,000
$11.9 P/Share
|
|
Jan 06
2023
|
Ana Radeljevic |
BUY
Open market or private purchase
|
Direct |
4,156
+50.0%
|
$49,872
$12.03 P/Share
|
|
Jan 03
2023
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
30,632
+2.16%
|
$336,952
$11.33 P/Share
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders